INVESTOR ALERT: Edelson Lechtzin LLP Reminds Enovix Corporation (NASDAQ: ENVX) Shareholders of Lead Plaintiff Deadline
24 janv. 2023 15h00 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP reminds investors who purchased Enovix Corporation (“Enovix”) (NASDAQ: ENVX) common stock between February 22, 2021, and January...
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Enovix Corporation (NASDAQ: ENVX) Shareholders
18 janv. 2023 12h28 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of purchasers and holders of Enovix Corporation. (“Enovix”)...
DATA BREACH ALERT: Edelson Lechtzin LLP Has Filed A Class Action Lawsuit On Behalf Of Patients Whose Personal Data May Have Been Compromised By Connexin Software Inc.’s Data Breach
15 déc. 2022 12h15 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Dec. 15, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Connexin Software Inc. (“Connexin” or the “Company”)...
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Twist Bioscience Corporation (NASDAQ: TWST) Shareholders
15 déc. 2022 12h12 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Dec. 15, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of all purchasers and holders of Twist Bioscience Corporation...
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Enviva Inc. (NYSE: EVA) Shareholders
13 déc. 2022 15h21 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Dec. 13, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of all purchasers and holders of Enviva Inc. (“Enviva” or the...
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) Shareholders
05 déc. 2022 12h07 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Dec. 05, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of all purchasers of Eiger BioPharmaceuticals, Inc. (“Eiger”)...
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Investors of U.S. Bancorp (NYSE: USB)
29 nov. 2022 14h04 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Nov. 29, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of investors of U.S. Bancorp (“U.S. Bancorp” or the “Company”)...
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Unisys Corporation (NYSE: UIS) Shareholders
09 nov. 2022 16h30 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of all purchasers of Unisys Corporation (“Unisys” or the...
INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Fulgent Genetics, Inc. (NASDAQ: FLGT) Shareholders
23 sept. 2022 09h51 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Sept. 23, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of purchasers of Fulgent Genetics, Inc. (“Fulgent” or the...
UPDATE -- Edelson Lechtzin LLP Reminds Enochian Biosciences, Inc. Investors of the Impending Lead Plaintiff Deadline
22 sept. 2022 20h17 HE
|
Edelson Lechtzin LLP
NEWTOWN, Pa., Sept. 22, 2022 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP reminds investors who purchased Enochian Biosciences Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB) common...